Cargando…
Knockdown of Lymphoid Enhancer factor 1 Inhibits Colon Cancer Progression In Vitro and In Vivo
Expression of lymphoid enhancer factor 1 (LEF1) is frequently altered in different human cancers. This study aimed to assess LEF1 expression in colon cancer tissues and to explore changed phenotypes, gene expressions, and the possible mechanism after knocked down LEF1 expression in colon cancer cell...
Autores principales: | Wang, Wen-Juan, Yao, Yu, Jiang, Li-Li, Hu, Ting-Hua, Ma, Jie-Qun, Liao, Zi-Jun, Yao, Jun-Tao, Li, Dong-Fan, Wang, Shu-Hong, Nan, Ke-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3788715/ https://www.ncbi.nlm.nih.gov/pubmed/24098538 http://dx.doi.org/10.1371/journal.pone.0076596 |
Ejemplares similares
-
Targeted Knockdown of IQGAP1 Inhibits the Progression of Esophageal Squamous Cell Carcinoma In Vitro and In Vivo
por: Wang, Xiao-Xia, et al.
Publicado: (2014) -
NUP160 knockdown inhibits the progression of diabetic nephropathy in vitro and in vivo
por: Xie, Jiayong, et al.
Publicado: (2022) -
Kynureninase knockdown inhibits cisplatin resistance in vivo and in vitro and impacts the prognosis of cervical adenocarcinoma
por: Zhang, Jun-wen, et al.
Publicado: (2023) -
Knockdown of MCM8 inhibits development and progression of bladder cancer in vitro and in vivo
por: Zhu, Wei, et al.
Publicado: (2021) -
Knockdown of GSG2 inhibits prostate cancer progression in vitro and in vivo
por: Yu, Feng, et al.
Publicado: (2020)